Prostatype Genomics AB (FRA:PGO) EV-to-Revenue : 173.05 (As of Sep. 25, 2024)

Prostatype Genomics AB EV-to-Revenue Chart

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
EV-to-Revenue	Get a 7-Day Free Trial												55.40	11.66	38.99	19.60	-

Competitive Comparison of Prostatype Genomics AB's EV-to-Revenue

For the Diagnostics & Research subindustry, Prostatype Genomics AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prostatype Genomics AB's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's EV-to-Revenue falls into.

Prostatype Genomics AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Prostatype Genomics AB's EV-to-Revenue for today is calculated as:

Prostatype Genomics AB's current Enterprise Value is €6.92 Mil.
Prostatype Genomics AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostatype Genomics AB  (FRA:PGO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Prostatype Genomics AB's PS Ratiofor today is calculated as:

Prostatype Genomics AB's share price for today is €0.0008.
Prostatype Genomics AB's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostatype Genomics AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description